Raleigh, N.C. – November 16, 2016 – Valencell, the leading innovator in performance biometric data sensor technology, announced today that its president and co-founder, Dr. Steven LeBoeuf, will present a session, “Connecting the Dots Between Mobile Fitness and Mobile Health,” at the IDTechEx Show on November 17, 2016 in Santa Clara, California.

The IDTechEx Show brings together the latest emerging technologies with global end-user brands, featuring nine conferences within one combined tradeshow. The event, which runs November 16 – 17, will feature over 250 speakers discussing the latest innovations in wearable technologies, sensors, and more.

Dr. LeBoeuf’s session will be featured as part of the IDTechEx Wearable USA 2016 and IDTechEx Sensors USA conferences. His session will discuss how high performance biometric sensor technology can connect the dots between mobile fitness technology and health data, providing new and impactful insights and enabling advancements in mobile healthcare, with a focus in prevention, screening, and disease management.

“With lower costs, better form-factors, and active signal characterization technology, wearables and hearables have improved to the point where they are accurate enough for numerous medical purposes,” said Dr. Steven LeBoeuf, president and co-founder of Valencell. “We are on the cusp of massive improvements in healthcare monitoring and delivery when companies can apply medical-grade accuracy to these innovative wearable sensor technologies and provide responsive healthcare interventions based on accurate sensor data.”

Valencell’s PerformTek® sensor systems provide accurate, robust and flexible technology, powering more biometric hearables and wearables on the market than any other company. The technology gives hearable devices the ability to continuously and accurately measure blood flow signals, even during extreme physical activity or when the optical signals are weak. These signals can be translated into biometric data, including continuous heart rate, VO2 and VO2 max, resting heart rate, heart rate response, heart rate recovery, continuous energy expenditure (calorie burn), cardiac efficiency and heart rate variability assessments.

Valencell provides its biometric sensor technology through it Benchmark™ sensor system, a turnkey biometric sensor system with the complete PerformTek technology package ready for immediate integration into wearable and hearable devices. Valencell also offers product licensing and patent licensing, to enable customers to create custom-designed biometric hearable and wearable devices.

The accuracy of Valencell’s PerformTek technology has been independently validated by numerous research institutions, including Duke University, NC State University, and the American College of Sports Medicine.

Valencell has a highly cited patent portfolio in optical biometric sensor technology in the wearables and hearables industry, which includes 37 patents granted and more than 70 additional patents pending.

Valencell’s PerformTek technology is the choice of popular consumer electronics brands, including Bose, Samsung, Sony, LG, Intel/SMS Audio, Jabra, Scosche, Atlas Wearables, Caeden, Kuaiwear, Bioconnected, and iriver among numerous others. To learn more about licensing PerformTek, visit valencell.com/access.

To set up a meeting with Dr. LeBoeuf at the event, please contact media@valencell.com.

About Valencell

Valencell develops performance biometric sensor technology and licenses this patent-protected technology to consumer electronics manufacturers, wearable and hearable device makers, sports and fitness brands, medical device makers, and gaming companies for integration into their products. Valencell’s PerformTek® biometric sensor technology employs active signal characterization, the process of segmenting raw signal data from biometric sensors into biological, motion, and environmental signals and noise. Valencell has invested years into the research and development of its PerformTek sensor technology, protected by dozens of granted patents and independently validated by the Duke Center for Living, North Carolina State University, the Human Performance Laboratory and a fellow of the American College of Sports Medicine.